Lybrate in fast company’s global list of 10 Most Innovative Companies in Healthcare

Lybrate, Inc. has recently announced that it has been recognized by Fast Company as a 10 Most Innovative Company in Healthcare for 2016, in its annual ranking of Most Innovative Companies.

Lybrate is the only healthcare startup from India that made it to the prestigious list. The company is democratizing healthcare in India by solving the core problem of Indian healthcare that is inaccessibility of doctors. Doctor crunch is a massive problem in India and so reaching out to them for an opinion on health-related ailments is a herculean task for many in the country.

“We are very honored at being recognized as the 10 Most Innovative Companies world over. It is a validation to our efforts of fixing the real problem of Indian healthcare that is inaccessibility of healthcare in the country, which has long been a serious issue. We are single-mindedly focusing on solving this core problem with innovative use of technology and enabling doctors and patients to communicate with each other online from anywhere, anytime. We are delighted to share the recognition with our users who guide us to innovate more and make the product more seamless and convenient to use,” said Saurabh Arora, CEO, Lybrate.

Since the launch of the Lybrate app in January 2015, the company has seen a massive growth with more than 90,000 doctors from across specialties currently associated with it. With more than 2 million downloads since launch and over 500,000 users visiting the platform every day, Lybrate’s popularity has been soaring rapidly in the country. Recognizing its popularity and potential, Apple recently featured Lybrate in its coveted list of ‘The App Store Best of 2015’ that covers most innovative apps and games. In addition to this, Forbes India featured Lybrate's co-founder Rahul Narang in its 30 under 30, 2016 list.

Through Most Innovative Companies, Fast Company honors every year enterprises and newcomers who are leading the pack in business innovation.